Published in Leukemia on October 01, 2004
Differential gene expression, GATA1 target genes, and the chemotherapy sensitivity of Down syndrome megakaryocytic leukemia. Blood (2005) 1.51
Malignancy in children with trisomy 21. Oncologist (2009) 1.12
Hematopoietic disorders in Down syndrome. Int J Clin Exp Pathol (2008) 1.09
Development of acute megakaryoblastic leukemia in Down syndrome is associated with sequential epigenetic changes. Blood (2013) 0.84
GATA1s induces hyperproliferation of eosinophil precursors in Down syndrome transient leukemia. Leukemia (2013) 0.81
Integrated differential transcriptome maps of Acute Megakaryoblastic Leukemia (AMKL) in children with or without Down Syndrome (DS). BMC Med Genomics (2014) 0.79
Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology (1998) 26.77
Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med (2004) 16.58
The pathogenesis and prevention of Rh immunization. Can Med Assoc J (1967) 4.07
Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells. J Exp Med (1998) 3.58
Predicting conversion to Alzheimer disease using standardized clinical information. Arch Neurol (2000) 3.37
Predicting changes in physical performance in a high-functioning elderly cohort: MacArthur studies of successful aging. J Gerontol (1994) 2.95
Herpes simplex virus triggers and then disarms a host antiviral response. J Virol (2001) 2.82
High, usual and impaired functioning in community-dwelling older men and women: findings from the MacArthur Foundation Research Network on Successful Aging. J Clin Epidemiol (1993) 2.77
Social relationships, social support, and patterns of cognitive aging in healthy, high-functioning older adults: MacArthur studies of successful aging. Health Psychol (2001) 2.69
Interleukin-6 and risk of cognitive decline: MacArthur studies of successful aging. Neurology (2002) 2.68
Aphasia rehabilitation resulting from melodic intonation therapy. Cortex (1974) 2.65
Fusion of two novel genes, RBM15 and MKL1, in the t(1;22)(p13;q13) of acute megakaryoblastic leukemia. Nat Genet (2001) 2.55
Thalidomide costimulates primary human T lymphocytes, preferentially inducing proliferation, cytokine production, and cytotoxic responses in the CD8+ subset. J Exp Med (1998) 2.39
Towards realistic estimates of HCV incidence in Egypt. J Viral Hepat (2012) 2.28
A predictive score for testicular sperm extraction quality and surgical ICSI outcome in non-obstructive azoospermia: a retrospective study. Hum Reprod (2011) 2.20
Assessing patient dependence in Alzheimer's disease. J Gerontol (1994) 2.16
Transanal minimally invasive surgery for total mesorectal excision (TAMIS-TME): a stepwise description of the surgical technique with video demonstration. Tech Coloproctol (2013) 1.97
Regionally-specific diffusion tensor imaging in mild cognitive impairment and Alzheimer's disease. Neuroimage (2009) 1.92
APOE epsilon 4 allele predicts faster cognitive decline in mild Alzheimer disease. Neurology (2008) 1.91
The role of APOE-epsilon4 in longitudinal cognitive decline: MacArthur Studies of Successful Aging. Neurology (2003) 1.85
Quality of life in patients with Alzheimer's disease as reported by patient proxies. J Am Geriatr Soc (1996) 1.78
Cost-effectiveness of antepartum prevention of Rh immunization. Clin Perinatol (1984) 1.71
The distinctive features of influenza virus infection of dendritic cells. Immunobiology (1998) 1.70
Longitudinal study of effects of patient characteristics on direct costs in Alzheimer disease. Neurology (2006) 1.65
The course of psychopathologic features in mild to moderate Alzheimer disease. Arch Gen Psychiatry (1997) 1.63
The hematology of bacterial infections in premature infants. Pediatrics (1976) 1.61
Multicenter study of predictors of disease course in Alzheimer disease (the "predictors study"). I. Study design, cohort description, and intersite comparisons. Alzheimer Dis Assoc Disord (1993) 1.60
Motor signs predict poor outcomes in Alzheimer disease. Neurology (2005) 1.60
Age at onset of Alzheimer's disease: relation to pattern of cognitive dysfunction and rate of decline. Neurology (1994) 1.60
Lack of opsonization potential of 11S human secretory A. Proc Soc Exp Biol Med (1973) 1.56
Robotic transanal surgery for local excision of rectal neoplasia, transanal total mesorectal excision, and repair of complex fistulae: clinical experience with the first 18 cases at a single institution. Tech Coloproctol (2015) 1.49
Motor signs during the course of Alzheimer disease. Neurology (2004) 1.47
Unfolding of microarray data. J Comput Biol (2001) 1.45
An empirical study of diagnostic criteria for delirium. Am J Psychiatry (1991) 1.42
Assessment of anemia in newborn infants. Clin Perinatol (1984) 1.32
Transanal minimally invasive surgery for total mesorectal excision (TAMIS-TME): results and experience with the first 20 patients undergoing curative-intent rectal cancer surgery at a single institution. Tech Coloproctol (2013) 1.31
RNA polymerase II subunit Rpb9 regulates transcription elongation in vivo. J Biol Chem (2000) 1.31
Transanal minimally invasive surgery (TAMIS): applications beyond local excision. Tech Coloproctol (2012) 1.30
Juvenile myelomonocytic leukemia and Noonan syndrome. J Pediatr Hematol Oncol (2000) 1.30
Early multi-institution experience with single-incision laparoscopic colectomy. Dis Colon Rectum (2011) 1.26
Multicenter study of predictors of disease course in Alzheimer disease (the "predictors study"). II. Neurological, psychiatric, and demographic influences on baseline measures of disease severity. Alzheimer Dis Assoc Disord (1993) 1.25
Association between the APOE genotype and psychopathologic symptoms in Alzheimer's disease. Neurology (2002) 1.25
Physician compliance and relapse rates of acute lymphoblastic leukemia in children. Clin Pharmacol Ther (1988) 1.24
Clinical and quantitative pathologic correlates of dementia with Lewy bodies. Neurology (1999) 1.24
Clinical features associated with costs in early AD: baseline data from the Predictors Study. Neurology (2006) 1.23
Self-efficacy beliefs and change in cognitive performance: MacArthur Studies of Successful Aging. Psychol Aging (1996) 1.23
A controlled study of the prevalence of cognitive dysfunction in randomly selected patients with systemic lupus erythematosus. Arthritis Rheum (1992) 1.19
Robotic transanal total mesorectal excision: a pilot study. Tech Coloproctol (2014) 1.17
The absence of an apolipoprotein epsilon4 allele is associated with a more aggressive form of Alzheimer's disease. Ann Neurol (1997) 1.17
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part III. Reliability of a standardized MRI evaluation of Alzheimer's disease. Neurology (1992) 1.16
Delirium after elective orthopedic surgery: risk factors and natural history. Int J Psychiatry Med (1989) 1.14
Leukemic reticuloendotheliosis. A failure of monocyte production. N Engl J Med (1976) 1.14
Vitamin K at birth. BMJ (1996) 1.13
Yersinia enterocolitica invasin triggers phagocytosis via beta1 integrins, CDC42Hs and WASp in macrophages. Cell Microbiol (2001) 1.13
Large human sperm vacuoles observed in motile spermatozoa under high magnification: nuclear thumbprints linked to failure of chromatin condensation. Hum Reprod (2011) 1.09
The clinical utility of the dementia rating scale for assessing Alzheimer patients. J Chronic Dis (1984) 1.09
Comparison of neurologic changes in 'successfully aging' persons vs the total aging population. Arch Neurol (1994) 1.09
An investigation of clinical correlates of Lewy bodies in autopsy-proven Alzheimer disease. Arch Neurol (2001) 1.09
Application of a growth curve approach to modeling the progression of Alzheimer's disease. J Gerontol A Biol Sci Med Sci (1996) 1.06
Neutrophil and band counts in the diagnosis of neonatal infections. Pediatrics (1974) 1.05
The nonerythropoietic component of early bilirubin. J Clin Invest (1968) 1.05
Participation in clinical trials and long-term outcomes in Alzheimer's disease. Neurology (1997) 1.05
Role of non-covalent enzyme-substrate interactions in the reaction catalysed by cellobiose phosphorylase from Cellulomonas uda. Biochem J (2000) 1.04
Essential thrombocythemia in children. J Pediatr Hematol Oncol (1999) 1.04
Comparison of receiver operating characteristic curves on the basis of optimal operating points. Acad Radiol (1996) 1.04
Lexical retrieval in healthy aging. Cortex (1985) 1.04
Neuropsychological predictors of dependency in patients with Alzheimer disease. Neurology (2005) 1.03
Thrombotic disease in newborn infants. Clin Perinatol (1984) 1.01
Cytogenetic and molecular studies of Down syndrome individuals with leukemia. Am J Hum Genet (1995) 1.01
Canine ocular onchocercosis in Hungary. Vet Parasitol (2001) 1.01
Familial palilalia. Neurology (1973) 1.00
Genetic association of an alpha2-macroglobulin (Val1000lle) polymorphism and Alzheimer's disease. Hum Mol Genet (1998) 0.99
Excision of a rectal neoplasm using robotic transanal surgery (RTS): a description of the technique. Tech Coloproctol (2012) 0.98
Toxicity of leukaemia therapy in children with Down syndrome. Lancet (1986) 0.97
Bone mineral density in sixty adult patients with Marfan syndrome. Osteoporos Int (1999) 0.97
The use of a lighted stent as a method for identifying the urethra in male patients undergoing transanal total mesorectal excision: a video demonstration. Tech Coloproctol (2015) 0.95
Ganglioside composition of an experimental mouse brain tumor. Cancer Res (1987) 0.95
A study of the efficacy of a comprehensive memory enhancement program in healthy elderly persons. Psychiatry Res (1998) 0.95
Comparison of the precision of two standardized co-ordinate systems for the quantitation of brain anatomy: preliminary results. Neuroradiology (1994) 0.94
Longitudinal study of quality of life in people with advanced Alzheimer's disease. Am J Geriatr Psychiatry (2001) 0.94
Robotic-assisted transanal surgery for total mesorectal excision (RATS-TME): a description of a novel surgical approach with video demonstration. Tech Coloproctol (2013) 0.92
Sulfhydryl groups of the erythrocyte membrane and their relation to glycolysis and drug-induced hemolytic anemia. J Clin Invest (1974) 0.91
Pathogenesis of primary respiratory disease induced by isolates from a new genetic cluster of bovine viral diarrhea virus type I. J Clin Microbiol (2001) 0.91
Prenatal diagnosis of brain abnormalities in Wolf-Hirschhorn (4p-) syndrome. Prenat Diagn (2002) 0.90
Does histologic grade have a role in the management of head and neck cancers? J Clin Oncol (2001) 0.90
Neuroprotective and anticonvulsant effects of EGIS-8332, a non-competitive AMPA receptor antagonist, in a range of animal models. Br J Pharmacol (2007) 0.90
The stereochemical course of the reaction mechanism of trehalose phosphorylase from Schizophyllum commune. FEBS Lett (1998) 0.90
Short-course oral prednisone therapy in children presenting with acute immune thrombocytopenic purpura (ITP). Acta Paediatr Suppl (1998) 0.90
Leukocyte density and volume in normal subjects and in patients with acute lymphoblastic leukemia. Blood (1976) 0.90
Selection of normal spermatozoa with a vacuole-free head (x6300) improves selection of spermatozoa with intact DNA in patients with high sperm DNA fragmentation rates. Andrologia (2012) 0.89
Palilalia. Br J Disord Commun (1975) 0.89
Vitamin C-induced erythrocyte damage in premature infants. J Pediatr (1988) 0.89
Antibodies to IGA in pregnancy and in recipient of Rh o (D) immune globulin (human). Transfusion (1973) 0.89
Mycobacterium xenopi and drinking water biofilms. Appl Environ Microbiol (2003) 0.89
A new variant translocation in acute promyelocytic leukaemia: molecular characterization and clinical correlation. Leukemia (1996) 0.89
The extracellular matrix molecule tenascin-R and its HNK-1 carbohydrate modulate perisomatic inhibition and long-term potentiation in the CA1 region of the hippocampus. Eur J Neurosci (2000) 0.89
Simultaneous measurements of temperature and pH in vivo using NMR in conjunction with TmDOTP5-. NMR Biomed (2000) 0.88
Cognitive differences between patients with progressive supranuclear palsy and Alzheimer's disease. J Clin Exp Neuropsychol (1989) 0.88